Abbott Laboratories (NYSE: ABT) Receives "Buy" Rating Amid Strong Growth Prospects
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameCap Gemini S.A.
-
Registration countryFrance
-
IndustryIT Services and Computer Programming
-
М/S&P/F
*** /*** /***









